Showing results (221-230 of 431) with videos related to
Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline UpdateAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumorsTimothy D Gilligan, Jerome Seidenfeld, Ethan M Basch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancerVered Stearns, Baljit Singh, Theodore Tsangaris, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activityVered Stearns, Ann Gallagher, Celina G Kleer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapyCarmen J Allegra, J Milburn Jessup, Mark R Somerfield, et al.Archives of Pathology & Laboratory Medicine|June 12, 2023
Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerAntonio C Wolff, Mark R Somerfield, Mitchell Dowsett, et al.Pharmacogenomics|January 23, 2016
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclinesDaniel L Hertz, Megan V Caram, Kelley M Kidwell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateHarold J Burstein, Sarah Temin, Holly Anderson, et al.American Journal of Obstetrics and Gynecology|June 18, 2019
Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancerAllison Gockley, Alexander Melamed, Angel Cronin, et al.Journal of Clinical Pharmacology|December 17, 2011
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozoleLauren Nicole Bell, Anne Thi Phuong Nguyen, Lang Li, et al.Pageof 44